Ignite Creation Date:
2024-05-06 @ 10:05 AM
Last Modification Date:
2024-10-26 @ 12:24 PM
Study NCT ID:
NCT03162874
Status:
COMPLETED
Last Update Posted:
2020-03-17
First Post:
2017-05-19
Brief Title:
Study to Evaluate the Efficacy Safety and Tolerability of PXT002331 Foliglurax in Reducing Motor Complications of Levodopa Therapy in Parkinson Diseases Patients
Sponsor:
Organization:
Prexton Therapeutics
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
157
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: